advertisement
Japanese Journal of Ophthalmology 43
Showing records 1 to 25 |
Display all abstracts in Japanese Journal of Ophthalmology106284 Two-year clinical outcomes of triple therapy with photodynamic therapy, anti-vascular endothelial growth factor agent, and triamcinolone acetonide for neovascular age-related macular degenerationAndo R
Japanese Journal of Ophthalmology 2023; 67: 50-58
105632 Factors associated with recurrence of bleb-related infectionsOzawa K
Japanese Journal of Ophthalmology 2022; 66: 559-571
106285 Epidemiology and characteristics of common forms of anterior uveitis at initial presentation in a tertiary facility in JapanOkazawa R
Japanese Journal of Ophthalmology 2023; 67: 22-31
106733 Ten-year outcomes of cataract surgery for glaucoma management in patients with primary angle-closure diseaseSakai D
Japanese Journal of Ophthalmology 2023; 67: 129-137
106494 Microhook ab interno trabeculotomy for secondary glaucoma in patients with hereditary transthyretin amyloidosisKitahara J
Japanese Journal of Ophthalmology 2023; 67: 84-90
105736 Intraocular pressure at different gaze positions in patients with highly myopic strabismusArai S
Japanese Journal of Ophthalmology 2022; 66: 572-578
106494 Microhook ab interno trabeculotomy for secondary glaucoma in patients with hereditary transthyretin amyloidosisKakihara S
Japanese Journal of Ophthalmology 2023; 67: 84-90
105736 Intraocular pressure at different gaze positions in patients with highly myopic strabismusSuzuki H
Japanese Journal of Ophthalmology 2022; 66: 572-578
106285 Epidemiology and characteristics of common forms of anterior uveitis at initial presentation in a tertiary facility in JapanIwai S
Japanese Journal of Ophthalmology 2023; 67: 22-31
106733 Ten-year outcomes of cataract surgery for glaucoma management in patients with primary angle-closure diseaseYamamoto S
Japanese Journal of Ophthalmology 2023; 67: 129-137
106284 Two-year clinical outcomes of triple therapy with photodynamic therapy, anti-vascular endothelial growth factor agent, and triamcinolone acetonide for neovascular age-related macular degenerationHirooka K
Japanese Journal of Ophthalmology 2023; 67: 50-58
105632 Factors associated with recurrence of bleb-related infectionsInuzuka M
Japanese Journal of Ophthalmology 2022; 66: 559-571
105736 Intraocular pressure at different gaze positions in patients with highly myopic strabismusHayashi S
Japanese Journal of Ophthalmology 2022; 66: 572-578
106285 Epidemiology and characteristics of common forms of anterior uveitis at initial presentation in a tertiary facility in JapanNagura K
Japanese Journal of Ophthalmology 2023; 67: 22-31
106284 Two-year clinical outcomes of triple therapy with photodynamic therapy, anti-vascular endothelial growth factor agent, and triamcinolone acetonide for neovascular age-related macular degenerationSaito M
Japanese Journal of Ophthalmology 2023; 67: 50-58
106494 Microhook ab interno trabeculotomy for secondary glaucoma in patients with hereditary transthyretin amyloidosisHirano T
Japanese Journal of Ophthalmology 2023; 67: 84-90
105632 Factors associated with recurrence of bleb-related infectionsMurata K
Japanese Journal of Ophthalmology 2022; 66: 559-571
106733 Ten-year outcomes of cataract surgery for glaucoma management in patients with primary angle-closure diseaseYoshimizu S
Japanese Journal of Ophthalmology 2023; 67: 129-137
106494 Microhook ab interno trabeculotomy for secondary glaucoma in patients with hereditary transthyretin amyloidosisTakahashi Y
Japanese Journal of Ophthalmology 2023; 67: 84-90
105632 Factors associated with recurrence of bleb-related infectionsIshihara T
Japanese Journal of Ophthalmology 2022; 66: 559-571
105736 Intraocular pressure at different gaze positions in patients with highly myopic strabismusInagaki R
Japanese Journal of Ophthalmology 2022; 66: 572-578
106733 Ten-year outcomes of cataract surgery for glaucoma management in patients with primary angle-closure diseaseHirose F
Japanese Journal of Ophthalmology 2023; 67: 129-137
106284 Two-year clinical outcomes of triple therapy with photodynamic therapy, anti-vascular endothelial growth factor agent, and triamcinolone acetonide for neovascular age-related macular degenerationKase S
Japanese Journal of Ophthalmology 2023; 67: 50-58
106285 Epidemiology and characteristics of common forms of anterior uveitis at initial presentation in a tertiary facility in JapanSora D
Japanese Journal of Ophthalmology 2023; 67: 22-31
106284 Two-year clinical outcomes of triple therapy with photodynamic therapy, anti-vascular endothelial growth factor agent, and triamcinolone acetonide for neovascular age-related macular degenerationNoda K
Japanese Journal of Ophthalmology 2023; 67: 50-58